IHPBA State of the Art Conference on Minimally Invasive Pancreatic Resection

Item

  • IHPBA State of the Art Conference on Minimally Invasive Pancreatic Resection

Early
(on or before 10 December 2015)

  • USD 125
    .
    .

Standard
(on or before 28 February 2016)

  • USD 200
    .
    .

Late

  • USD 250
    .
    .

On-site

  • USD 250
    .
    .

.

The participant registration fee for the IHPBA State of the Art Conference on Minimally Invasive Pancreatic Resection includes

  • Admission to the IHPBA State of the Art Conference on Minimally Invasive Pancreatic Resection
  • IHPBA State of the Art Conference on Minimally Invasive Pancreatic Resection documentation
  • Tea/coffee
  • Lunch (Wednesday 20, April)

April 20 – Wednesday - 07:30-17:00 hrs - WTC Theater – WTC

The MIPR “State of the Art” conference will take place over one day at the start of the 2016 IHPBA World Congress. It will examine the current state of the art of MIPR from the prospective of what we know and what we need to learn. The areas of discussion are set out below and will include the results of an international MIPR survey. Speakers and panellists include open and laparoscopic/robotic surgeons as well as other leaders in pancreatic advocacy.

07:30 Introduction  
P. Jagannath, MD Welcome
  Charles Vollmer, MD Genesis of the conference
  David Kooby, MD Overview of the day
  Claudio Bassi, MD Identifying key outcome metrics in pancreatic surgery
  André Montagnini, MD Standardizing terminology for MIPR
  Marc Besselink, MD Results from an international survey on MIPR
08:20 Distal Pancreatectomy  
  Bård Røsok, MD Moderator
  Markus Diener, MD Perioperative outcomes of minimally invasive distal pancreatectomy
  David Kooby, MD Cancer outcomes for minimally invasive distal pancreatectomy
  Peter Allen, MD Patient selection and approach (laparoscopic vs. robot vs. open)
     
  Panel moderator Shailesh Shrikhande, MD
  Panel Peter Allen, MD
    Ho-Seong Han, MD
    Nipun Merchant, MD
    Masafumi Nakamura, MD
    Nicholas O'Rourke, MD
    Patrick Pessaux, MD
09:35 Break  
09:50 Pancreatoduodenectomy  
  Ugo Boggi, MD Moderator
  R. Matthew Walsh, MD Perioperative outcomes of minimally invasive pancreatoduodenectomy
  Michael Kendrick, MD Cancer outcomes for minimally invasive pancreatoduodenectomy
  Herb Zeh, MD Pro/con Robotic Approach
  Steven Hughes, MD Pro/con Laparoscopic Approach
  Yoshiharu Nakamura, MD Pro/con Assisted Approach
  Charles Vollmer, MD Pro/con Open Approach
10:40 Cost / Value / Quality of Life  
  Kevin Conlon, MD Moderator
  Mohammed Abu Hilal, MD What do we already know about cost and value of MIPR?
  Tsafrir Vanounou, MD The framework for cost comparisons moving forward
  Mark Talamonti, MD Investing in an MIPR program: a chairman’s perspective
  Vic Velanovich, MD Assessing QOL when adopting novel surgical approaches
  Julie Fleshman (President and CEO, Pancreatic Cancer Action Network) The patients’ experience: what patients think and care about
11:40 Pancreatoduodenectomy Panel Discussion  
  Panel moderator Horacio Asbun, MD
  Panel Markus Büchler, MD
    Mark Callery, MD
    Michael Farnell, MD
    John Martinie, MD
    C. Palanivelu, MD
    Richard Schulick, MD
    Herb Zeh, MD
12:10 Box Lunch / Continued discussion period  
13:10 Training/Credentialing  
  Herb Zeh, MD Moderator
  Paul Hansen, MD How MIS affects HPB training
Steven Strasberg, MD Adopting new technology in the age of outcome scrutiny
  Marc Besselink, MD Organized dissemination of MIPR pancreatectomy
  Melissa Hogg, MD Decreasing the learning curve for minimally invasive pancreatoduodenectomy
  Oliver Varban, MD Video review as a method of assessing surgical performance
  Henry Pitt, MD NSQIP as a measure of pancreatic surgical competence
  James Moser, MD Credentialing for low volume complex procedures
     
  Panel moderator Paul Hansen, MD
  Panel Pierre Clavien, MD
    Abe Fingerhut, MD
    Rohan Jeyarajah, MD
    James Moser, MD
    Henry Pitt, MD
    Oliver Varban, MD
    Herb Zeh, MD
14:50 Break  
15:05 Registry  
  Jeffrey Barkun, MD Moderator
  William Fisher, MD Can we do a clinical trial comparing open and MIPR?
  Giana Davidson, MD Registries: what you should know
  Jane Holt (Co-founder of National Pancreas Foundation) Experience with registry development
     
  Panel moderator Jeffrey Barkun, MD
  Panel Marc Besselink, MD
    Giana Davidson, MD
    Henry Pitt, MD
    Go Wakabayashi, MD
16:05 Open Forum and Concluding Remarks  
  David Kooby, MD and Charles Vollmer, MD: Conference Co-directors